WebApr 10, 2024 · April 10, 2024. ASTHO, in consultation with CDC, created a tool to assess the needs and capacity of recipients of CDC’s Overdose Data to Action (OD2A) cooperative agreement to incorporate health equity into its overdose prevention and surveillance efforts. The OD2A Health Equity Needs Assessment is designed to assess the support, technical ... WebMar 8, 2024 · As a complementary effort to the Overdose Data to Action: LOCAL NOFO, CDC is concurrently offering an opportunity tailored to state jurisdictions, called …
Nwanne O. - Epidemiologist - CDC Foundation LinkedIn
WebThe prevention component will strengthen prescription drug monitoring programs, improve state-local integration, establish linkages to care and improve provider and health system support. This program builds upon the previous CDC program, Data-Driven Prevention Initiative. More information on the OD2A grant or previous CDC grants. WebOverdose Data to Action in States (OD2A-S) will fund state health departments and the District of Columbia to expand their surveillance efforts to track fatal and non-fatal overdoses, emerging drug threats, and associated risk factors, and to enhance biosurveillance and data linkage. OD2A-S provides continued support of clinician … hand foot and mouth disease lasts how long
ftp.cdc.gov
Webftp.cdc.gov - /pub/OD2A-S/ ... 2024 9:21 AM 1439891 OD2A in States _Applicant Info Calls_Final.pdf Thursday, March 23, 2024 9:24 AM 296388 OD2A-S Strategy Resource … WebJun 10, 2024 · OD2A is a cooperative agreement (CDC-RFA-CE19-1904) funded in 2024 to focus on comprehensive and interdisciplinary opioid overdose prevention efforts in 47 state health departments, 16 localities, Puerto Rico, Washington DC, and the North Mariana Islands. This program consists of two required components—a surveillance component … WebMar 12, 2024 · Currently, CDC funds 47 states and Washington, D.C., 2 territories, and 16 large city and county health departments through OD2A. In 2024, CDC will build on this essential program, leveraging the latest epidemiology, prevention research, and lessons learned from the prior OD2A cycle. hand foot and mouth disease mayo clinic